SE8602917L - Furosemidsalter - Google Patents

Furosemidsalter

Info

Publication number
SE8602917L
SE8602917L SE8602917A SE8602917A SE8602917L SE 8602917 L SE8602917 L SE 8602917L SE 8602917 A SE8602917 A SE 8602917A SE 8602917 A SE8602917 A SE 8602917A SE 8602917 L SE8602917 L SE 8602917L
Authority
SE
Sweden
Prior art keywords
dosage forms
furosemide
bioavailable
affording
burden
Prior art date
Application number
SE8602917A
Other languages
English (en)
Swedish (sv)
Other versions
SE8602917D0 (sv
Inventor
L Chafetz
J Philip
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of SE8602917D0 publication Critical patent/SE8602917D0/xx
Publication of SE8602917L publication Critical patent/SE8602917L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
SE8602917A 1985-07-02 1986-07-01 Furosemidsalter SE8602917L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/751,763 US4663348A (en) 1985-07-02 1985-07-02 Furosemide salts and pharmaceutical preparations thereof

Publications (2)

Publication Number Publication Date
SE8602917D0 SE8602917D0 (sv) 1986-07-01
SE8602917L true SE8602917L (sv) 1987-01-03

Family

ID=25023379

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8602917A SE8602917L (sv) 1985-07-02 1986-07-01 Furosemidsalter

Country Status (14)

Country Link
US (1) US4663348A (fr)
JP (1) JPS625975A (fr)
AU (1) AU599034B2 (fr)
BE (1) BE904986A (fr)
CH (1) CH670448A5 (fr)
DE (1) DE3619665A1 (fr)
DK (1) DK312586A (fr)
FR (1) FR2584405B1 (fr)
GB (1) GB2189239B (fr)
IT (1) IT1191972B (fr)
LU (1) LU86484A1 (fr)
NL (1) NL8601519A (fr)
SE (1) SE8602917L (fr)
ZA (1) ZA864207B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4920145A (en) * 1988-02-29 1990-04-24 Gaf Chemical Corporation Water-soluble complexes of water-insoluble pharmaceutical compounds and preparation thereof
IT1237115B (it) * 1989-10-24 1993-05-18 Sali della furosemide, procedimento per la loro preparazione e composizionni farmaceutiche che li contengono
AU654831B2 (en) * 1991-12-03 1994-11-24 Kokuyo Kabushiki Kaisha Filing device openable/closable on both sides
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
FI114538B (fi) * 2001-01-12 2004-11-15 Finnfeeds Finland Ltd Glysiinibetaiinin käyttö verenpainetta alentavan tuotteen valmistukseen
US6989386B2 (en) * 2002-04-30 2006-01-24 Dana-Farber Cancer Institute Pharmaceutically active ornithine derivatives, ammonium salts thereof and methods of making same
RU2557237C2 (ru) 2010-02-10 2015-07-20 Киссеи Фармасьютикал Ко., Лтд. Соль конденсированного гетероциклического производного и его кристаллы
JP6415535B2 (ja) * 2013-04-05 2018-10-31 エスシーファーマシューティカルズ インコーポレイテッド フロセミドの皮下投与用の医薬製剤
WO2020141224A1 (fr) 2019-01-04 2020-07-09 Sq Innovation Ag Compositions pharmaceutiques de furosémide et leurs utilisations
CA3128033A1 (fr) 2019-01-31 2020-08-06 Scpharmaceuticals Inc. Formulations pharmaceutiques liquides concentrees de furosemide et leurs methodes d'administration

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3058882A (en) * 1959-12-28 1962-10-16 Hoechst Ag N'-substituted-3-carboxy-6-halo-sulfanilamide and derivatives thereof
US3565920A (en) * 1966-12-29 1971-02-23 Ciba Geigy Corp 5-sulfamyl-anthranilic acids
DK138322B (da) * 1970-07-13 1978-08-14 Dumex Ltd As Fremgangsmåde til fremstilling af N-substituered antranilsyrederivater.
FR2210607A1 (en) * 1972-12-20 1974-07-12 Aries Robert 4-Chloro-5-sulphamoyl-N-furfuryl-anthranilic acid prepn. - from furfural and 4-chloro-5-sulphamoyl anthranilic acid
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets
LU74319A1 (fr) * 1976-02-09 1977-08-19
DE3025367A1 (de) * 1980-07-04 1982-01-28 Hoechst Ag, 6000 Frankfurt Salz aus furosemid oder piretanid als saeurekomponente und penbutolol oder (-)-3-(4- (3-(3,4-dimethoxyphenylaethylamino)-2-hydroxy-propoxy) -phenyl ) -crotonsaeurenitril als basenkomponente, verfahren zu seiner herstellung, dieses enthaltendes mittel und dessen verwendung

Also Published As

Publication number Publication date
NL8601519A (nl) 1987-02-02
FR2584405A1 (fr) 1987-01-09
SE8602917D0 (sv) 1986-07-01
GB2189239A (en) 1987-10-21
AU599034B2 (en) 1990-07-12
ZA864207B (en) 1987-02-25
IT8648183A0 (it) 1986-06-25
CH670448A5 (fr) 1989-06-15
AU5889086A (en) 1987-01-08
FR2584405B1 (fr) 1989-02-24
LU86484A1 (fr) 1986-12-02
GB2189239B (en) 1989-02-01
DK312586D0 (da) 1986-07-01
JPS625975A (ja) 1987-01-12
US4663348A (en) 1987-05-05
DE3619665A1 (de) 1987-01-08
BE904986A (fr) 1986-12-24
IT1191972B (it) 1988-03-31
GB8615275D0 (en) 1986-07-30
DK312586A (da) 1987-01-03

Similar Documents

Publication Publication Date Title
DE3587941T2 (de) Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
SE8602917L (sv) Furosemidsalter
IT8721668A0 (it) Insufflatore per la somministrazione di farmaci sottoforma di polvere predosata in opercoli.
DE3682457D1 (de) Geraet zur verabreichung von medikamenten an patienten.
SE8605515D0 (sv) A liquid dosage form for oral administration of a pharmaceutically active substance
DE227494T1 (de) Pharmazeutische zusammensetzung vom fluessig/gel-phasenuebergangstyp.
DK642587D0 (da) Insulinpraeparat
BG85941A (bg) Лекарствена форма с контролирано освобождаване и метод за получаването й
GR76810B (fr)
NO863029D0 (no) Farmasoeytisk doseringsenhet.
DE3863678D1 (de) Lithiumsalze enthaltende pharmazeutische zubereitungen.
SE8402098D0 (sv) Perfluorkarbonemulsion, framstellning derav samt dess anvendning i terapi
IT8223147A0 (it) Preparato farmaceutico equilibrato idrodinamicamente dotato di cessione protratta della sostanza attiva.
DE68909409T2 (de) Heilmitteldosierung zur verabreichung an fische.
DK390585D0 (da) Kontrastmiddel og fremgangsmaade til anvendelse heraf
EA200200151A1 (ru) Сухая порошкообразная композиция
SE8303003L (sv) Medel for att oka antitumorverkan hos antitumormedel
DK23386D0 (da) Pyridopyrimidiner, deres fremstilling og anvendelse som laegemidler
NO863625D0 (no) Medikamentdoseringsanordning.
ES2082023T3 (es) Soluciones inyectables listas para su utilizacion que contienen un agente antitumoral del tipo antraciclina glucosido.
MX9203782A (es) Forma de dosis con capacidad de administracion mejorada.
DK515285D0 (da) Imidazoliumsalte med blodsukker-saenkende virkning og farmaceutiske midler indeholdende saadanne forbindelser
ES548988A0 (es) Procedimiento de solubilizacion,en el momento del empleo,de un principio activo lipofilo en una solucion acuosa,con ob- jeto de su administracion por via intravenosa
DE3650368T2 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
DE3677181D1 (de) Wasserfreie, selektive, ionendurchlaessige elektroden zur untersuchung bestimmter ionen in waessrigen loesungen.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8602917-0

Effective date: 19920201